Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
boston top stories
cancer
4
×
life sciences
national blog main
new york blog main
4
×
national top stories
clinical trials
foundation medicine
adeno-associated virus
beam therapeutics
biotech week boston
bristol-myers squibb
broad institute
bwb
cancer immunotherapy
center for medicare and medicaid services
chemotherapy
cindy perettie
cisplatin
codiak biosciences
companion diagnostic
crispr
cutaneous t-cell lymphoma
daniel o'day
david liu
deals
decibel therapeutics
editas medicine
exosome
fda
foundationone cdx
foundationone heme
gene therapy
genentech
hearing loss
immuno-oncology
jazz pharmaceuticals
What
medicine
medicines
acquire
adding
ago
agreed
aiming
balance
based
begin
benefiting
big
billion
biosciences
bio’s
boston
brings
broad
bubbles
build
cells
class
clinical
codiak
coming
confidence
decibel
diagnostics
didn’t
drugs
emerged
exosome
exosomes
focus
formed
forms
foundation
fund
gain
genentech
Language
unset
Current search:
boston
×
cancer
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
